Literature DB >> 12354755

Kinetic analysis of the interleukin-13 receptor complex.

Allison-Lynn Andrews1, John W Holloway, Sarah M Puddicombe, Stephen T Holgate, Donna E Davies.   

Abstract

Interleukin (IL)-13 is a key cytokine associated with the asthmatic phenotype. It signals via its cognate receptor, a complex of IL-13 receptor alpha1 chain (IL-13Ralpha1) with IL-4Ralpha; however, a second protein, IL-13Ralpha2, also binds IL-13. To determine the binding contributions of the individual components of the IL-13 receptor to IL-13, we have employed surface plasmon resonance and equilibrium binding assays to investigate the ligand binding characteristics of shIL-13Ralpha1, shIL-13Ralpha2, and IL-4Ralpha. shIL-13Ralpha1 bound IL-13 with moderate affinity (K(D) = 37.8 +/- 1.8 nm, n = 10), whereas no binding was observed for hIL-4Ralpha. In contrast, shIL-13Ralpha2 produced a high affinity interaction with IL-13 (K(D) = 2.49 +/- 0.94 nm n = 10). IL-13Ralpha2 exhibited the binding characteristics of a negative regulator with a fast association rate and an exceptional slow dissociation rate. Although IL-13 interacted weakly with IL-4Ralpha on its own (K(D) > 50 microm), the presence of hIL-4Ralpha significantly increased the affinity of shIL-13Ralpha1 for IL-13 but had no effect on the binding affinity of IL-13Ralpha2. Detailed kinetic analyses of the binding properties of the heteromeric complexes suggested a sequential mechanism for the binding of IL-13 to its signaling receptor, in which IL-13 first binds to IL-13Ralpha1 and this then recruits IL-4Ralpha to stabilize a high affinity interaction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354755     DOI: 10.1074/jbc.M209560200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Transgenic modelling of cytokine polarization in the lung.

Authors:  Charles S Dela Cruz; Min-Jong Kang; Won-Kyung Cho; Chun Geun Lee
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

2.  Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.

Authors:  Larisa J Geskin; Sara Viragova; Donna B Stolz; Patrizia Fuschiotti
Journal:  Blood       Date:  2015-01-27       Impact factor: 22.113

3.  Cooperative epigenetic modulation by cancer amplicon genes.

Authors:  Lixin Rui; N C Tolga Emre; Michael J Kruhlak; Hye-Jung Chung; Christian Steidl; Graham Slack; George W Wright; Georg Lenz; Vu N Ngo; Arthur L Shaffer; Weihong Xu; Hong Zhao; Yandan Yang; Laurence Lamy; R Eric Davis; Wenming Xiao; John Powell; David Maloney; Craig J Thomas; Peter Möller; Andreas Rosenwald; German Ott; Hans Konrad Muller-Hermelink; Kerry Savage; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Dennis D Weisenburger; Wing C Chan; Randy D Gascoyne; David Levens; Louis M Staudt
Journal:  Cancer Cell       Date:  2010-12-14       Impact factor: 31.743

Review 4.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

5.  Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity.

Authors:  Ilkka S Junttila; Kiyoshi Mizukami; Harold Dickensheets; Martin Meier-Schellersheim; Hidehiro Yamane; Raymond P Donnelly; William E Paul
Journal:  J Exp Med       Date:  2008-10-13       Impact factor: 14.307

6.  Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.

Authors:  Patrizia Fuschiotti; Adriana T Larregina; Johnan Ho; Carol Feghali-Bostwick; Thomas A Medsger
Journal:  Arthritis Rheum       Date:  2013-01

7.  Pharmacokinetic and pharmacodynamic modeling of a humanized anti-IL-13 antibody in naive and Ascaris-challenged cynomolgus monkeys.

Authors:  Yulia Vugmeyster; Xianbin Tian; Pamela Szklut; Marion Kasaian; Xin Xu
Journal:  Pharm Res       Date:  2008-10-31       Impact factor: 4.200

8.  Distinct structural requirements for interleukin-4 (IL-4) and IL-13 binding to the shared IL-13 receptor facilitate cellular tuning of cytokine responsiveness.

Authors:  Takachika Ito; Shoichi Suzuki; Sachiko Kanaji; Hiroshi Shiraishi; Shoichiro Ohta; Kazuhiko Arima; Go Tanaka; Taro Tamada; Eijiro Honjo; K Christopher Garcia; Ryota Kuroki; Kenji Izuhara
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

Review 9.  IL-13 receptor isoforms: breaking through the complexity.

Authors:  Yasuhiro Tabata; Gurjit K Khurana Hershey
Journal:  Curr Allergy Asthma Rep       Date:  2007-09       Impact factor: 4.806

10.  Expression of excess receptors and negative feedback control of signal pathways are required for rapid activation and prompt cessation of signal transduction.

Authors:  Hiroshi Kobayashi; Ryuzo Azuma; Takuo Yasunaga
Journal:  Cell Commun Signal       Date:  2009-03-03       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.